This is problematic because vitamin B12 deficiency can cause permanent neurological effects
A few other open-label studies, mainly from India, reported improved short-term outcomes with FMT, but the inclusion criteria and comparator arms were not consistent [89,90]
\Safety Profile: Mild, transient side effects
CagriSema is a fixed-dose combination therapy comprising two molecules administered together in a single once-weekly subcutaneous injection: semaglutide 2.4 mg, a glucagon-like peptide-1 (GLP-1) receptor agonist already approved for weight management as Wegovy, and cagrilintide 2.4 mg, a long-acting analogue of amylin, a hormone involved in appetite regulation and satiety signalling
Ad-on material Some clinics add vitamin C, alpha-lipoic acid or collagen boosters to increase the effect